Delisted
This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
MRNS (MARINUS PHARMACEUTICALS INC) is held by 0 institutional investors as of Q1 2025.
0
Holders
(1 Elite)
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold MRNS.
Top Holders
Checking access…
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $138,535 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $30,569 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $147 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8,574 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6,901 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $24,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $16,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $472,854 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $5,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $29 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $36,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $152,569 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3,239 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $12,237 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $134,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $53,966 | 0.0% | — | 0 |
Showing 1-20 of 37
1 / 2
MRNSMARINUS PHARMACEUTICALS INCContinue exploring
Other Unknown stocks held by institutions
FISVFISERV INC346 holders · $23.2B
SPYSTATE STREET SPDR S&P 500 ETF TRUST CL USD INC295 holders · $273.1B
IVVISHARES CORE S&P 500 ETF266 holders · $436.8B
VOOVANGUARD S&P 500 ETF245 holders · $223.6B
IWMISHARES RUSSELL 2000 ETF ETF243 holders · $61.3B
GLDSPDR GOLD TRUST242 holders · $39.3B
QQQINVESCO QQQ TRUST SERIES 1 CL USD INC240 holders · $91.3B
XLFFINANCIAL SELECT SECTOR SPDR224 holders · $30.2B
EFAISHARES MSCI EAFE ETF CL USD INC222 holders · $44B
IEMGISHARES CORE MSCI EMERGING216 holders · $93.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer